Shares Held (Direct Ownership) 12.2K
n/a 3M change
n/a 12M change
Total Value Held N/A

Adam D. Levy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2025
SELL
Payment of exercise price or tax liability
$1,466 $1.26 p/Share
1,164 Reduced 8.74%
12,151 Common Stock
ADL

Adam D. Levy

Chief Financial Officer
Watertown, MA

Track Institutional and Insider Activities on ACRV

Follow Acrivon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRV shares.

Notify only if

Insider Trading

Get notified when an Acrivon Therapeutics, Inc. insider buys or sells ACRV shares.

Notify only if

News

Receive news related to Acrivon Therapeutics, Inc.

Track Activities on ACRV